SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: sommovigo who wrote (2214)6/19/2000 1:46:00 PM
From: peter michaelson  Read Replies (1) | Respond to of 3392
 
Hey sommovigo, on Raging Bull they won't even answer the question, but I'm sure you will if asked civilly.

What is the reason that sales of the EHC in the U.S. may be expected to be successful, when apparently European sales are nearly non-existent.

I try to be open minded, so please point me to a rational answer rather than saying "ignore the basher". Thanks

peter



To: sommovigo who wrote (2214)6/19/2000 1:56:00 PM
From: StockDung  Read Replies (2) | Respond to of 3392
 
Smelly buy reports by crappy analysts were CYBR's downfall. That and all the hype. Thats why people lost money on CYBR. It was greed. Lets not forget the crappy companies CYBR mad deals with and contracts with so pump and dumpers could hype it on the internet. People that claim to be in the inner circle and had information prior to it being made public.

When will one reputable analyst recommend CYBR? Oh where oh where can he or she be?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News